Abbott Laboratories (ABT): Are Hedge Funds Right About This Stock?

Page 1 of 2

Abbott Laboratories (NYSE:ABT) was in 50 hedge funds’ portfolio at the end of December. ABT investors should be aware of a decrease in support from the world’s most elite money managers lately. There were 54 hedge funds in our database with ABT positions at the end of the previous quarter. An important piece of news came in this morning saying that Abbott Laboratories (NYSE:ABT) got a new Neutral rank at Credit Suisse.

FIX Hedge Funds Are Crazy About Abbott Laboratories (NYSE:ABT)

In the eyes of most traders, hedge funds are viewed as underperforming, old financial tools of years past. While there are greater than 8000 funds with their doors open at present, we at Insider Monkey choose to focus on the moguls of this club, about 450 funds. It is estimated that this group has its hands on the majority of the hedge fund industry’s total capital, and by keeping an eye on their best investments, we have found a few investment strategies that have historically outperformed the S&P 500 index. Our small-cap hedge fund strategy outpaced the S&P 500 index by 18 percentage points annually for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have topped the S&P 500 index by 24 percentage points in 7 months (explore the details and some picks here).

Equally as integral, positive insider trading sentiment is another way to parse down the stock market universe. As the old adage goes: there are many incentives for an executive to cut shares of his or her company, but only one, very simple reason why they would initiate a purchase. Several academic studies have demonstrated the impressive potential of this tactic if shareholders understand what to do (learn more here).

With these “truths” under our belt, we’re going to take a gander at the latest action surrounding Abbott Laboratories (NYSE:ABT).

What have hedge funds been doing with Abbott Laboratories (NYSE:ABT)?

At the end of the fourth quarter, a total of 50 of the hedge funds we track were bullish in this stock, a change of -7% from the previous quarter. With the smart money’s sentiment swirling, there exists a select group of noteworthy hedge fund managers who were boosting their stakes considerably.

According to our comprehensive database, Southeastern Asset Management, managed by Mason Hawkins, holds the most valuable position in Abbott Laboratories (NYSE:ABT). Southeastern Asset Management has a $455.5 million position in the stock, comprising 2% of its 13F portfolio. On Southeastern Asset Management’s heels is Southeastern Asset Management, managed by Mason Hawkins, which held a $244.9 million position; the fund has 1.1% of its 13F portfolio invested in the stock. Some other peers that hold long positions include Ric Dillon’s Diamond Hill Capital, Cliff Asness’s AQR Capital Management and Phill Gross and Robert Atchinson’s Adage Capital Management.

Seeing as Abbott Laboratories (NYSE:ABT) has witnessed bearish sentiment from the smart money, it’s safe to say that there lies a certain “tier” of hedge funds that decided to sell off their positions entirely in Q4. Intriguingly, Ricky Sandler’s Eminence Capital dropped the largest stake of the “upper crust” of funds we watch, comprising an estimated $81.3 million in stock., and Christopher Medlock James of Partner Fund Management was right behind this move, as the fund sold off about $61.3 million worth. These bearish behaviors are intriguing to say the least, as aggregate hedge fund interest fell by 4 funds in Q4.

How are insiders trading Abbott Laboratories (NYSE:ABT)?

Insider trading activity, especially when it’s bullish, is best served when the company in focus has experienced transactions within the past half-year. Over the latest half-year time period, Abbott Laboratories (NYSE:ABT) has seen 1 unique insiders purchasing, and 11 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Abbott Laboratories (NYSE:ABT). These stocks are St. Jude Medical, Inc. (NYSE:STJ), Zimmer Holdings, Inc. (NYSE:ZMH), Intuitive Surgical, Inc. (NASDAQ:ISRG), Stryker Corporation (NYSE:SYK), and Medtronic, Inc. (NYSE:MDT). This group of stocks belong to the medical appliances & equipment industry and their market caps are closest to ABT’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!